UL

Integromics announces winners of grant competition

Friday, July 8, 2011 12:38 PM

Integromics has announced the two winners of the Integromics “Proteomics Mass Spectrometry Research Grant” competition for the creative use of Integromics' OmicsHub proteomics solution.

More... »

Grant awarded for heart research

Wednesday, July 6, 2011 10:34 AM

The Medical College of Wisconsin (MCW) and Cellular Dynamics International (CDI) have announced receipt of a research grant award from the National Heart, Lung, and Blood Institute (NHLBI) to investigate the mechanisms underlying Left Ventricular Hypertrophy.

More... »

AcelRx gets $20M loan

Tuesday, July 5, 2011 12:00 PM

AcelRx Pharmaceuticals has secured a $20 million loan from Hercules Technology Growth Capital, according to FierceBiotech.

More... »

Triple alliance forged to create end-to-end therapeutic discovery platform

Wednesday, June 29, 2011 12:14 PM

Three U.K.-based biotech companies, Isogenica, Biolauncher and Cresset Biomolecular Discovery, have formed a collaborative joint venture, according to the U.K.’s Business Weekly.

More... »

Five European CROs merge to form NEOX Europe

Friday, June 24, 2011 10:40 AM

Five independent CROs with operations stretching from Eastern to Western Europe have grouped together to form a new entity that will “act as one team and one company,” according to a report from PharmaTimes.

More... »

Amsterdam Molecular Therapeutics shows data supporting role of chylomicron clearance as marker for Glybera efficacy

Friday, May 20, 2011 11:10 AM

Amsterdam Molecular Therapeutics, a company involved in the field of human gene therapy, has results from a long-term efficacy study of Glybera (alipogene tiparvovec) that showed improved chylomicron metabolism could be used as a biomarker for increased lipoprotein lipase (LPL) activity in those patients missing the gene that produces this protein. Glybera is a gene therapy product under development for the treatment of lipoprotein lipase deficiency (LPLD) that is currently under review for marketing approval with the EMA.

More... »

Quintiles collaborates with PGT

Tuesday, May 17, 2011 11:32 AM

Quintiles has partnered with Population Genetics Technologies (PGT), a U.K.-based company that specializes in large-scale, lower-cost genomic analyses, according to PharmaTimes.

More... »

Rules-Based Medicine partners with Institut Pasteur

Friday, May 13, 2011 11:50 AM

Texas-based Rules-Based Medicine (RBM), a provider of multiplexed protein biomarker services will be a collaborator on the Institut Pasteur research project Milieu Interieur (the environment within), funded through a LabEx grant from the French government.  The project will rely on RBM's TruCulture, an innovative in vitro model that preserves physiological cellular interactions, to more accurately describe the complexities of the human immune system.

More... »

Robb Watters appointed vice chair of board for GW Medical

Tuesday, May 10, 2011 12:14 PM

The GW Medical Faculty Associates, an independent physician group practice in metropolitan Washington, has appointed Robb Watters vice chairman of its board of trustees.

More... »

Allergan and Molecular Partners enter into license agreement

Wednesday, May 4, 2011 12:29 PM

Allergan and Molecular Partners have entered into a license agreement for MP0112, a phase II proprietary therapeutic DARPin(r) protein targeting VEGF under investigation for the treatment of retinal diseases.

More... »